Skip to main content
| News

Basel presents itself as center of innovation at the House of Switzerland in Tokyo

15.03.2021

Around a dozen innovative companies and institutions from the Basel Area are planning a joint marketing presence in Tokyo under the motto "Basel is changing your life". The appearance at the House of Switzerland in Tokyo on the occasion of the Olympic Games had to be postponed from 2020 to 2021 and is now picking up speed again.

Under the motto “Basel is changing your life”, innovative showcases from the life sciences sector will be made accessible to an interested public in Tokyo in July. The focus is on innovations from the biotech and medtech sectors that were developed in Basel or have a strong connection to the region. These include new methods for personalized medication, non-invasive health tests or wearable sensor devices for digital health monitoring. A virtual reality goggle, with which surgeons can plan complex interventions, or a cognitive robotic assistance system for operations are also intended to exemplify the innovative strength of Basel as a location.

All of these innovations claim to positively influence and change lives. “The globally networked innovation location Basel Area is a focal point for technologies and business models that make people’s lives better. This is made possible by a dynamic ecosystem with a unique density of life sciences companies, technology startups, renowned research institutions, business-friendly framework conditions and outstanding quality of life,” says Christof Klöpper, CEO of Basel Area Business & Innovation, summing up the exceptional strength of the location.

The planned marketing presence during the Olympic Games in Tokyo follows on from earlier location marketing campaigns in the USA and Europe and aims to strengthen the region’s position in international location competition. “It is and remains an ongoing task to make the strengths of our region known to the relevant target groups both nationally and internationally,” says Sabine Horvath, Head of External Relations and Location Marketing, on the overarching goal of the marketing presence.

“The partners involved see the joint presence in Tokyo as an opportunity to develop new ideas for forward-looking solutions and to find partners,” explains Hans-Florian Zeilhofer, Delegate for Innovation at the University of Basel. With the planned presentation of Basel’s innovation projects in Asia, this will also attract international attention.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.